Search results
Results from the WOW.Com Content Network
Ensitrelvir has been investigated for use as potential post-exposure prophylaxis (PEP) for SARS-CoV-2 infection. [20] [21] The SCORPIO-PEP trial, a global Phase 3 study, assessed the safety and efficacy of ensitrelvir in preventing symptomatic COVID-19 among household contacts of individuals with confirmed SARS-CoV-2 infection.
A pharmacist may tell someone who is COVID-19 positive that they need to be evaluated further for Paxlovid eligibility by a health care provider, including a doctor, under certain terms, according ...
The principal for obstetric management of COVID-19 include rapid detection, isolation, and testing, profound preventive measures, regular monitoring of fetus as well as of uterine contractions, peculiar case-to-case delivery planning based on severity of symptoms, and appropriate post-natal measures for preventing infection.
The results of this study confirm the suspicions of child and youth care professionals that the COVID-19 lockdown has negative effects on the mental and social health of children and adolescents. In opinion papers, professionals elaborated on the vulnerability of this group and expected more feelings of loneliness, anxiety and depression, as ...
For premium support please call: 800-290-4726 more ways to reach us
Several over-the-counter Covid-19 tests were authorized by the FDA for use without a prescription, offering a way for schools and workplaces to conduct serial testing.
Anxiety about COVID-19 makes people more willing to "try anything" that might give them a sense of control of the situation, making them easy targets for scams. [5] Many false claims about measures against COVID-19 have circulated widely on social media, but some have been circulated by text, on YouTube, and even in some mainstream media ...
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...